EE03451B1 - Immunomodulaatorid - Google Patents

Immunomodulaatorid

Info

Publication number
EE03451B1
EE03451B1 EE9700029A EE9700029A EE03451B1 EE 03451 B1 EE03451 B1 EE 03451B1 EE 9700029 A EE9700029 A EE 9700029A EE 9700029 A EE9700029 A EE 9700029A EE 03451 B1 EE03451 B1 EE 03451B1
Authority
EE
Estonia
Prior art keywords
immunomodulators
Prior art date
Application number
EE9700029A
Other languages
English (en)
Other versions
EE9700029A (et
Inventor
Gr�nh�j Larsen Christian
Gesser Borbala
Original Assignee
Steeno Research Group A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steeno Research Group A/S filed Critical Steeno Research Group A/S
Publication of EE9700029A publication Critical patent/EE9700029A/et
Publication of EE03451B1 publication Critical patent/EE03451B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EE9700029A 1994-07-05 1995-06-07 Immunomodulaatorid EE03451B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK80094 1994-07-05
PCT/DK1995/000227 WO1996001318A1 (en) 1994-07-05 1995-06-07 Immunomodulators

Publications (2)

Publication Number Publication Date
EE9700029A EE9700029A (et) 1997-08-15
EE03451B1 true EE03451B1 (et) 2001-06-15

Family

ID=8097707

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700029A EE03451B1 (et) 1994-07-05 1995-06-07 Immunomodulaatorid

Country Status (28)

Country Link
US (3) US6159937A (et)
EP (2) EP1013764A1 (et)
JP (1) JPH10502249A (et)
CN (1) CN1216992C (et)
AP (1) AP690A (et)
AT (1) ATE195003T1 (et)
AU (1) AU686816B2 (et)
BR (1) BR9508243A (et)
CA (1) CA2194444C (et)
CZ (1) CZ1497A3 (et)
DE (1) DE69518156T2 (et)
DK (1) DK0769054T3 (et)
EE (1) EE03451B1 (et)
ES (1) ES2148525T3 (et)
FI (1) FI970009A (et)
GR (1) GR3034628T3 (et)
HK (1) HK1012416A1 (et)
HU (1) HU220344B (et)
MX (1) MX9606537A (et)
NO (1) NO970020L (et)
NZ (1) NZ287406A (et)
PL (1) PL181042B1 (et)
PT (1) PT769054E (et)
RO (1) RO118758B1 (et)
RU (1) RU2218348C2 (et)
SK (1) SK283096B6 (et)
UA (1) UA57702C2 (et)
WO (1) WO1996001318A1 (et)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides
SE9501067D0 (sv) 1995-03-24 1995-03-24 Astra Ab New peptides
WO1997026278A1 (en) * 1996-01-18 1997-07-24 Steeno Research Group A/S Synthetic il-10 analogues
US20030124125A1 (en) * 1996-04-05 2003-07-03 South Alabama Medical Science Foundation Oncofetal antigen specific T-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10
NZ332412A (en) * 1996-05-02 2000-05-26 Schering Corp use of interleuklin-10 for treating or preventing ischemia-reperfusion injury
FR2748938B1 (fr) * 1996-05-22 1998-07-31 Pasteur Institut Utilisation de molecules antagonistes de chemokines pour leur activite antivirale notamment contre un retrovirus de type vih
SE9603463D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603468D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
US6086868A (en) * 1997-04-30 2000-07-11 Schering Corporation Method for treating or preventing ischemia-reperfusion injury
JP2001519381A (ja) * 1997-10-10 2001-10-23 インペリアル・カレッジ・イノベイションズ・リミテッド 子宮収縮管理のためのｃｓａｉｄｔｍ化合物の使用
CA2356010A1 (en) * 1998-12-22 2000-06-29 Schering Corporation Treatment of hepatitis c virus infections with interleukin-10
ATE292177T1 (de) * 1999-05-25 2005-04-15 Canji Inc Gentherapy von lungenkrankheiten
JP2005500247A (ja) * 2000-12-07 2005-01-06 ボード　オブ　リージェンツ，　ザ　ユニバーシティ　オブ　テキサス　システム ヒトｍｄａ−７に関わる処置方法
WO2002057283A1 (en) * 2001-01-19 2002-07-25 Baylor College Of Medecine Methods and compositions in breast cancer diagnosis and therapeutics
US20040086896A1 (en) * 2001-04-19 2004-05-06 Julie Carman Polynucleotides and polypeptides associated with the NF-kB pathway
CA2474360A1 (en) * 2002-02-11 2003-08-21 Arkion Life Sciences Llc Purified cytokine inhibitory factor
AU2003228267A1 (en) * 2002-03-05 2003-09-22 Board Of Regents, The University Of Texas System Methods of enhancing immune induction involving mda-7
EP1444989A1 (en) * 2003-02-07 2004-08-11 Giorgio Dr. Stassi Sensitizing cells for apoptosis by selectively blocking cytokines
CA2524534C (en) * 2003-05-15 2012-12-11 Sek Chung Fung Methods and compositions for the prevention and treatment of sepsis
US7261882B2 (en) 2003-06-23 2007-08-28 Reagents Of The University Of Colorado Methods for treating neuropathic pain by administering IL-10 polypeptides
US20050164244A1 (en) * 2003-10-23 2005-07-28 David Glass Methods of determining juvenile arthritis classification
US8034790B2 (en) * 2003-12-01 2011-10-11 Introgen Therapeutics Use of MDA-7 to inhibit pathogenic infectious organisms
US8034773B2 (en) 2004-02-05 2011-10-11 Arizona Biomedical Research Commission Immunostimulatory compositions and uses thereof
US20070281041A1 (en) * 2004-03-02 2007-12-06 Introgen Therapeutics, Inc. Compositions and Methods Involving MDA-7 for the Treatment of Cancer
US8178649B2 (en) * 2004-12-07 2012-05-15 Arizona Biomedical Research Commission Immunostimulatory compositions and uses thereof
GB0500643D0 (en) * 2005-01-13 2005-02-23 Renovo Ltd Medicaments
EP1863516A2 (en) * 2005-02-08 2007-12-12 Board of Regents, The University of Texas System Compositions and methods involving mda-7 for the treatment of cancer
EP1901769A2 (en) * 2005-05-02 2008-03-26 Avigen, Inc. Use of cytokine-derived peptides in treatment of pain and neurodegenerative disease
US8114964B2 (en) * 2005-05-19 2012-02-14 Centocor, Inc. Anti-MCP-1 antibodies, compositions, methods and uses
ES2696824T3 (es) 2005-05-31 2019-01-18 Univ Colorado Regents Métodos para suministrar genes
CA2656379A1 (en) * 2006-06-21 2007-12-27 Apogenix Gmbh Differential cytokine expression in human cancer
WO2008003514A2 (en) * 2006-07-06 2008-01-10 Apogenix Gmbh Human il-4 muteins in combination with chemotherapeutics or pro-apoptotic agents in cancer therapy
US8460697B2 (en) * 2006-12-13 2013-06-11 Susavion Biosciences, Inc. Pro-angiogenic peptides and uses thereof
US7838497B2 (en) * 2006-12-13 2010-11-23 Susavion Biosciences, Inc. Pro-angiogenic peptides
USRE46425E1 (en) 2006-12-13 2017-06-06 Susavion Biosciences, Inc. Pro-angiogenic peptides and uses thereof
CN101391103B (zh) * 2008-07-31 2013-07-24 张可 一种预防和治疗艾滋病病毒感染的药物组合物
WO2010022227A1 (en) * 2008-08-20 2010-02-25 Schering Corporation Methods for monitoring il-10 therapy
WO2011047097A2 (en) * 2009-10-13 2011-04-21 Sigalov Alexander B Inhibition of trem receptor signaling with peptide variants
RU2013145283A (ru) * 2011-03-14 2015-04-20 Флого АпС Новые антагонисты рецептора интерлейкина-1
SG11201404850SA (en) 2012-02-13 2014-09-26 Agency Science Tech & Res IL-1β NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES
ES2760902T3 (es) 2013-07-18 2020-05-18 Xalud Therapeutics Inc Composición para el tratamiento de la enfermedad articular inflamatoria
JP6140566B2 (ja) * 2013-07-31 2017-05-31 アイシン・エィ・ダブリュ株式会社 コイル装着方法及びコイル装着治具
CN105944086B (zh) * 2016-06-13 2017-08-25 浙江生创精准医疗科技有限公司 Il‑8单独或与其他细胞因子联合在治疗肝纤维化中的用途
KR20190091325A (ko) 2016-12-07 2019-08-05 프로제너티, 인크. 위장관 검출 방법, 디바이스 및 시스템
EP3600414A1 (en) 2017-03-30 2020-02-05 Progenity Inc. Treatment of a disease of the gastrointestinal tract with il-10 or an il-10 agonist
IL283268B1 (en) 2018-11-19 2024-05-01 Biora Therapeutics Inc Methods and devices for treating the disease with hyperpoietic substances
CN113711038A (zh) * 2019-01-31 2021-11-26 积水医疗株式会社 用于生物样品中游离aim的免疫分析方法及用于检测对象中nash的方法
WO2021119482A1 (en) 2019-12-13 2021-06-17 Progenity, Inc. Ingestible device for delivery of therapeutic agent to the gastrointestinal tract

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
KR100271197B1 (ko) * 1991-08-06 2000-11-01 둘락 노먼 씨. 인터루킨-10동족체또는길항제를포함하는내독소-또는초항원유도된독성치료용의약제학적조성물
CA2131524A1 (en) * 1992-03-04 1993-09-16 Maria-Grazia Roncarolo Use of interleukin-10 to suppress graft-vs.-host disease
CA2085291A1 (en) * 1992-07-30 1994-01-31 Martin L. Breitman Novel receptor tyrosine kinase
ES2111769T3 (es) * 1992-08-20 1998-03-16 Schering Corp Nuevos usos de il-10.
HUT73463A (en) * 1993-07-26 1996-08-28 Schering Corp Agonists and antagonists of human interleukin-10

Also Published As

Publication number Publication date
NO970020D0 (no) 1997-01-03
BR9508243A (pt) 1997-10-21
JPH10502249A (ja) 1998-03-03
EP1013764A1 (en) 2000-06-28
DE69518156T2 (de) 2001-01-11
ATE195003T1 (de) 2000-08-15
CA2194444A1 (en) 1996-01-18
PL181042B1 (pl) 2001-05-31
SK161496A3 (en) 1997-08-06
AP9700962A0 (en) 1997-04-30
HK1012416A1 (en) 1999-07-30
CN1159830A (zh) 1997-09-17
NZ287406A (en) 1998-07-28
DK0769054T3 (da) 2000-11-13
MX9606537A (es) 1997-12-31
US6159937A (en) 2000-12-12
EE9700029A (et) 1997-08-15
AU686816B2 (en) 1998-02-12
WO1996001318A1 (en) 1996-01-18
PL319429A1 (en) 1997-08-04
EP0769054A1 (en) 1997-04-23
PT769054E (pt) 2000-11-30
SK283096B6 (sk) 2003-02-04
CZ1497A3 (en) 1997-05-14
EP0769054B1 (en) 2000-07-26
ES2148525T3 (es) 2000-10-16
UA57702C2 (uk) 2003-07-15
RU2218348C2 (ru) 2003-12-10
HUT76673A (en) 1997-10-28
FI970009A0 (fi) 1997-01-02
US6599501B1 (en) 2003-07-29
CN1216992C (zh) 2005-08-31
GR3034628T3 (en) 2001-01-31
HU220344B (hu) 2001-12-28
US6168791B1 (en) 2001-01-02
RO118758B1 (ro) 2003-10-30
NO970020L (no) 1997-03-05
AP690A (en) 1998-10-16
AU2612195A (en) 1996-01-25
FI970009A (fi) 1997-03-04
DE69518156D1 (de) 2000-08-31
HU9603615D0 (en) 1997-02-28
CA2194444C (en) 2003-01-14

Similar Documents

Publication Publication Date Title
DK0769054T3 (da) Immunmodulatorer
ATA166795A (de) Bis-resorcinyltriazine
ATA147195A (de) Alkoxyphenyl-substituierte bisbenzoylphosphinoxide
ATA163695A (de) 2-hydroxyphenyltriazine
BR9507091A (pt) Combinações insecticidamente ativas
ATA108995A (de) Differenzdruckakkumulator
ATA11894A (de) Stauförderbahn
ATE197372T1 (de) Vorteig
FIU940322U0 (fi) Snabbkopplad roterbar svaenganordning foer graevmaskinsskopa
BR9403098A (pt) Turnimetro
BR9400287A (pt) Bi-vaso sanitário
BR9400290A (pt) Selo-contrato
BR7401742U (pt) Sub-capacete
BR9400154A (pt) Telaprotege
ATA127394A (de) Holografischer neurochip
FI944591A0 (fi) Bogportskonstruktion foer fartyg
BR7400030U (pt) Numeralfa
FIU940402U0 (fi) Underlagsknapp foer tvaolbit
BR7400053U (pt) T-compacto
BR7400062U (pt) Prato-bandeja
BR7400170U (pt) Mouráo
BR7400242U (pt) Tele-comando
BR7402083U (pt) Chuveiro-balde
BR7402342U (pt) Hidro-potenciômetro
ITRM940509A0 (it) Stereosistemafotomek

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

MM4A Lapsed by not paying the annual fees

Effective date: 20050607